Bax Expression Is Predictive of Favorable Clinical Outcome in Chemonaive Advanced Gastric Cancer Patients Treated with Capecitabine, Oxaliplatin, and Irinotecan Regimen

OBJECTIVE: Bax protein is a key mediator of apoptosis, and it might be related to chemosensitivity. The purpose of this study was to evaluate the prognostic role of Bax in patients with advanced gastric cancer treated with triplet chemotherapy COI regimen (capecitabine, oxaliplatin, and irinotecan)....

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Pietrantonio, Filippo, Biondani, Pamela, de Braud, Filippo, Pellegrinelli, Alessandro, Bianchini, Giampaolo, Perrone, Federica, Formisano, Barbara, Di Bartolomeo, Maria
Formato: Artigo
Idioma:Inglês
Publicado: Neoplasia Press Inc. 2012
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3384269/
https://ncbi.nlm.nih.gov/pubmed/22741034
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares